Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...

ImmunoGenesis has initiated the first subject dosing in a multicentre Phase I/II trial of IMGS-101 (evofosfamide), the ...

The GRPG-based model can predict patient outcomes and immunotherapy efficacy ... indicating a higher abundance of cancer cells in the high-risk group than in the low-risk group. The ssGSEA algorithm ...

Driving Innovation of Cancer Immunotherapy BOT has demonstrated ... enhancing T-cell infiltration and antitumor responses in preclinical models. These findings provide a strong rationale for ...

"As we already knew, immune cell infiltration in the tumor ... Lilian Marie Boll et al, Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent ...

Cancer immunotherapy is a therapy used to treat cancer patients that involves or uses components of the immune system. Some cancer immunotherapies consist of antibodies that bind to, and inhibit ...

The findings, published in the Journal for ImmunoTherapy of Cancer, could lead to new types of immunotherapy that rely on this novel strategy. "The approach we studied here could eventually become ...